ÂÜÀòÂÒÂ×

With his broad expertise as biotech entrepreneur, Claus serves as CEO of Affiris AG i.L as well as Affiris CVD GmbH.

Claus is a serial entrepreneur in the Life Sciences with 20 years’ experience in the Industry. In 2001, he cofounded Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) and executed the listing of the Company at NASDAQ as CFO, playing a key role in transforming Pieris from a biotech Start-up to a mature biopharmaceutical company.

Claus also cofounded XL-protein GmbH and led the Company to profitability through a series of collaborations with Pharma and Biotech. Claus also supports other biotech companies in part-time management positions. He holds a Master's degree in Business Administration from the University of Bamberg, Germany.